Journal of the American College of Surgeons
Volume 209, Issue 4 , Pages 461-467 , October 2009

Prognostic Significance of Intraoperatively Estimated Surgical Stage in Curatively Resected Gastric Cancer Patients

  • Sang Eok Lee, MD

      Affiliations

    • Gastric Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang-si, Republic of Korea
    • ,
  • Keun Won Ryu, MD

      Affiliations

    • Gastric Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang-si, Republic of Korea
    • Corresponding Author InformationCorrespondence address: Keun Won Ryu, MD, Gastric Cancer Branch, Research Institute and Hospital, National Cancer Center, Korea, 111 Jungbalsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, 410-769, Republic of Korea
    • ,
  • Byung Ho Nam, PhD

      Affiliations

    • Cancer Registration and Biostatistics Branch, Research Institute and Hospital, National Cancer Center, Goyang-si, Republic of Korea
    • ,
  • Jun Ho Lee, MD

      Affiliations

    • Gastric Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang-si, Republic of Korea
    • ,
  • Il Ju Choi, MD

      Affiliations

    • Gastric Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang-si, Republic of Korea
    • ,
  • Myeong-Cherl Kook, MD

      Affiliations

    • Gastric Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang-si, Republic of Korea
    • ,
  • Sook Ryun Park, MD

      Affiliations

    • Gastric Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang-si, Republic of Korea
    • ,
  • Young-Woo Kim, MD

      Affiliations

    • Gastric Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang-si, Republic of Korea

Received 26 March 2009 ,Revised 30 May 2009 ,Accepted 2 June 2009.

References 

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;5:74–108
  2. Shin HR, Jung KW, Won YJ. National cancer incidence for the year 2002 in Korea. Cancer Res Treat. 2007;39:139–149
  3. Siewert JR, Bottcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg. 1998;228:449–461
  4. Hohenberger P, Gretschel S. Gastric cancer. Lancet. 2003;362:305–315
  5. Kattan MW, Karpeh MS, Mazumdar M, Brennan MF. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol. 2003;21:3647–3650
  6. Peeters KC, Kattan MW, Hartgrink HH, et al. Validation of a nomogram for predicting disease-specific survival after an R0 resection for gastric carcinoma. Cancer. 2005;103:702–707
  7. Novotny AR, Schuhmacher C, Busch R, et al. Predicting individual survival after gastric cancer resection: validation of a U.S.-derived nomogram at a single high-volume center in Europe. Ann Surg. 2006;243:74–81
  8. Lieto E, Ferraraccio F, Orditura M, et al. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients. Ann Surg Oncol. 2008;15:69–79
  9. Maeda K, Kang SM, Onoda N, et al. Expression of p53 and vascular endothelial growth factor associated with tumor angiogenesis and prognosis in gastric cancer. Oncology. 1998;55:594–599
  10. Schweizer W, Reinhart A, Wagner HE, et al. Pre-, intra- and postoperative staging of gastric carcinoma and clinical outcome. Int Surg. 1995;80:204–207
  11. Korenaga D, Okuyama T, Orita H, et al. Role of intraoperative assessment of lymph node metastasis and serosal invasion in patients with gastric cancer. J Surg Oncol. 1994;55:250–254
  12. Japanese Gastric Cancer A. Japanese classification of gastric carcinoma. 2nd English ed. Gastric Cancer. 1998;1:10–24
  13. Nakajima T. Gastric cancer treatment guidelines in Japan. Gastric Cancer. 2002;5:1–5
  14. Sobin LH, Wittenking C. International Union Against Cancer (UICC) TNM classification of malignant tumours. In: 5th ed.. New York: Wiley-Liss; 1997;p. 59–62
  15. Martin RC, Jaques DP, Brennan MF, Karpeh M. Extended local resection for advanced gastric cancer: increased survival versus increased morbidity. Ann Surg. 2002;236:159–165
  16. Kim JP. Surgical results in gastric cancer. Semin Surg Oncol. 1999;17:132–138
  17. Araya M, Terashima M, Takagane A, et al. Microvessel count predicts metastasis and prognosis in patients with gastric cancer. J Surg Oncol. 1997;65:232–236
  18. Cheong JH, Hyung WJ, Shen JG, et al. The N ratio predicts recurrence and poor prognosis in patients with node-positive early gastric cancer. Ann Surg Oncol. 2006;13:377–385
  19. Marchet A, Mocellin S, Ambrosi A, et al. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg. 2007;245:543–552
  20. Chan AO, Chu KM, Lam SK, et al. Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer. J Clin Oncol. 2003;21:2288–2293
  21. de Manzoni G, Di Leo A, Pedrazzani C, et al. Intraoperative US staging of T in gastric cancer: final results of a blind prospective study. J Surg Oncol. 2001;78:158–161
  22. Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810–1820

 Disclosure Information: Nothing to disclose.

PII: S1072-7515(09)00558-4

doi: 10.1016/j.jamcollsurg.2009.06.001

Journal of the American College of Surgeons
Volume 209, Issue 4 , Pages 461-467 , October 2009

Article Tools

* Image Usage & Resolution